Sign In
Buy URGN
$26.60
+0.0600 (+0.226%)
At Close: Jun 03, 2026
Contact Levi & Korsinsky by July 28, 2025 to Join Class Action Against UroGen Pharma Ltd. (URGN)
08:15am, Wednesday, 11'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 11, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
URGN LEGAL REMINDER: UroGen Pharma Ltd. Securities Class Action Could allow Shareholders to Recover Losses; Contact BFA Law by July 28
07:46am, Wednesday, 11'th Jun 2025
NEW YORK CITY, NY / ACCESS Newswire / June 11, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certai
Securities Lawsuit Alert: UroGen Pharma Ltd. (URGN) - Contact Levi & Korsinsky Before July 28, 2025
07:30am, Wednesday, 11'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 11, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK CITY, NY / ACCESS Newswire / June 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UroGen
Investors in UroGen Pharma Ltd. (URGN): Protect Your Rights - Contact Levi & Korsinsky Before July 28, 2025
07:00pm, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
July 28, 2025 Deadline: Join Class Action Lawsuit Against UroGen Pharma Ltd. (URGN) - Contact Levi & Korsinsky
04:00pm, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
Securities Class Action Lawsuit Filed Against UroGen Pharma Ltd. (URGN) - Levi & Korsinsky Represents Shareholders
02:45pm, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit
02:30pm, Tuesday, 10'th Jun 2025
NEW YORK , June 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Pharma
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against UroGen
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in UroGen Pharma Ltd. ("UroGen Pharma Ltd." or the "Company") (NASDAQ: URGN) of a class action securities lawsuit.
Investor Alert: Deadline Approaching to Join UroGen Pharma Ltd. (URGN) Class Action - Contact Levi & Korsinsky
10:45am, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
UroGen: Despite ODAC Vote, Hope Remains With Targeting Of Other Cancer Subpopulation
10:30am, Tuesday, 10'th Jun 2025
PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The 7 m
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen
10:17am, Tuesday, 10'th Jun 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UroGen To Contact Him Directly To Discuss Their Options If you purchased or acquired
Securities Lawsuit Alert: UroGen Pharma Ltd. (URGN) Investors - Contact Levi & Korsinsky Before July 28, 2025
09:15am, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
URGN LEGAL NOTICE: Lose Money when UroGen Pharma Ltd. Stock Plummeted 45%?
08:47am, Tuesday, 10'th Jun 2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the
